Axsome Therapeutics, Inc.
AXSMPharmaceutical Preparations · SIC 2834 · CIK 0001579428
Revenue FY2025
$638.0M
Net Income
$(183.0M)
EPS (Basic)
$-3.68
Net Margin
-28.7%
ROE
-207.5%
Total Equity
$88.0M
Shares Out
52M
Axsome Therapeutics, Inc. — Pharmaceutical Preparations. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2014–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.
Revenue & Net Income (10Y)
Margin Trends
Investor Ownership · 9 funds in our universe
FundPosition Value% of AUMQoQ ChgWeight
Torray Funds
Torray
$3.7M
0.5%
+1.0%
Royce & Associates
Royce & Associates
$22.3M
0.2%
(3.2%)
OrbiMed Advisors
OrbiMed Advisors
$28.8M
0.1%
(45.0%)
Adage Capital Management
Adage Capital Management
$63.4M
0.1%
(64.9%)
Renaissance Technologies
Renaissance Technologies
$64.1M
0.1%
+59.5%
WCM Investment Management
WCM Investment Management
$18.3M
0.0%
(29.8%)
Motley Fool Asset Management
Motley Fool Asset Management
$0.4M
0.0%
NEW
Bridgewater Associates
Bridgewater Associates
$14.2M
0.0%
+2.2%
Polen Capital Management
Polen
$1.1M
0.0%
+111.2%
Insider Transactions
Reading stored insider transactions…